On the reactive states of astrocytes in prion diseases

References

• Dallérac G, Zapata J, Rouach N. Versatile control of synaptic circuits by astrocytes: where, when and how? Nat Rev Neurosci. 2018 2018/12/01;19(12):729–743.
   PubMed Web of Science ®Google Scholar
• Santello M, Toni N, Volterra A. Astrocyte function from information processing to cognition and cognitive impairment. Nat Neurosci. 2019 Feb 1;22(2):154–166.
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010 Jan 1;119(1):7–35.
   PubMed Web of Science ®Google Scholar
• Makarava N, Chang JC-Y, Kushwaha R, et al. Region-specific response of astrocytes to prion infection [original research]. Front Neurosci. 2019 Oct 9;13(1):e1048.
   PubMedGoogle Scholar
• Bradford BM, Wijaya CAW, Mabbott NA. Discrimination of prion strain targeting in the central nervous system via reactive astrocyte heterogeneity in CD44 expression [original research]. Front Cell Neurosci. 2019 Sept 10;13(411). DOI:https://doi.org/10.3389/fncel.2019.00411
   Google Scholar
• Ben Haim L, M-a C-DS, Ceyzériat K, et al. Elusive roles for reactive astrocytes in neurodegenerative diseases [Review]. Front Cell Neurosci. 2015 Aug 3;9(278): e278.
   PubMedGoogle Scholar
• Oksanen M, Lehtonen S, Jaronen M, et al. Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms. Cell Mol Life Sci. 2019 July 1;76(14):2739–2760.
   PubMed Web of Science ®Google Scholar
• Acioglu C, Li L, Elkabes S. Contribution of astrocytes to neuropathology of neurodegenerative diseases. Brain Res. 2021 Jan;28:147291.
   Google Scholar
• Habib N, McCabe C, Medina S, et al. Disease-associated astrocytes in Alzheimer’s disease and aging. Nat Neurosci. 2020 Jun;23(6):701–706.
   PubMed Web of Science ®Google Scholar
• Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021 Mar;24(3):312–325.
   PubMed Web of Science ®Google Scholar
• Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391–6410.
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46(6):957–967.
   PubMed Web of Science ®Google Scholar
• Morrissette DA, Parachikova A, Green KN, et al. Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem. 2009 Mar 6;284(10):6033–6037.
   PubMed Web of Science ®Google Scholar
• Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018 Oct 1;21(10):1370–1379.
   PubMed Web of Science ®Google Scholar
• Friedman BA, Srinivasan K, Ayalon G, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer’s disease not evident in mouse models. Cell Rep. 2018;22(3):832–847.
   PubMed Web of Science ®Google Scholar
• Watts JC, Prusiner SB. Mouse models for studying the formation and propagation of prions. J Biol Chem. 2014 Jul 18;289(29):19841–19849.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, et al. Generating a prion bacterially expressed recombinant prion protein. Science. 2010;327(5969):1132–1135.
   PubMed Web of Science ®Google Scholar
• Makarava N, Kovacs GG, Savtchenko R, et al. A new mechanism for transmissible Prion diseases. J Neurosci. 2012;32(21):7345–7355.
   PubMed Web of Science ®Google Scholar
• Makarava N, Kovacs GG, Savtchenko R, et al. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathogen. 2011;7(12):e1002419.
   PubMed Web of Science ®Google Scholar
• Deleault NR, Walsh DJ, Piro JR, et al. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. ProcAcadNatlSciUSA. 2012;109(28):E1938–E1946.
   PubMed Web of Science ®Google Scholar
• Makarava N, Chang JC-Y, Molesworth K, et al. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism. Neurobiol Dis. 2020 Apr 1;137(1):e104783.
   PubMedGoogle Scholar
• Makarava N, Chang JC-Y, Molesworth K, et al. Posttranslational modifications define course of prion strain adaptation and disease phenotype. J Clin Invest. 2020 Aug 3;130(8):4382–4395.
   PubMed Web of Science ®Google Scholar
• Hartmann K, Sepulveda-Falla D, Rose IVL, et al. Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia [journal article]. Acta Neuropathol Commun. 2019 May 22;7(1):83.
   PubMedGoogle Scholar
• Scheckel C, Imeri M, Schwarz P, et al. Ribosomal profiling during prion disease uncovers progressive translational derangement in glia but not in neurons. Elife. 2020 Sep 22;9. DOI:https://doi.org/10.7554/eLife.62911
   Google Scholar
• Carroll JA, Race B, Williams K, et al. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection. Mol Brain. 2020 May 7;13(1):71.
   PubMed Web of Science ®Google Scholar
• Makarava N, Mychko O, Chang JC-Y, et al. The degree of astrocyte activation is predictive of the incubation time to prion disease. Acta Neuropathol Commun. 2021 May 12;9(1):87.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Striebel JF, Rangel A, et al. Prion strain differences in accumulation of PrPSc on neurons and glia are associated with similar expression profiles of neuroinflammatory genes: comparison of three prion strains. PLoS Pathog. 2016;12(4):e1005551.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Makarava N, Savtchenko R, et al. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles. Am J Pathol. 2013;183(5):1539–1547.
   PubMed Web of Science ®Google Scholar
• Kushwaha R, Sinha A, Makarava N, et al. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases. Acta Neuropathol Commun. 2021 Feb 5;9(1):22.
   PubMed Web of Science ®Google Scholar
• Smith HL, Freeman OJ, Butcher AJ, et al. Astrocyte unfolded protein response induces a specific reactivity state that causes non-cell-autonomous neuronal degeneration. Neuron. 2020 Mar 4;105(5):855–866.e5.
   PubMed Web of Science ®Google Scholar
• Choi YP, Head MW, Ironside JW, et al. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes. Am J Pathol. 2014;184(12):3299–3307.
   PubMed Web of Science ®Google Scholar
• Hollister JR, Lee KS, Dorward DW, et al. Efficient uptake and dissemination of scrapie prion protein by astrocytes and fibroblasts from adult hamster brain. PLOS ONE. 2015;10(1):e0115351.
   PubMed Web of Science ®Google Scholar
• Jeffrey M, McGovern G, Makarava N, et al. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongoform encephalopathies. NeuropathApplNeurobiol. 2014;40(3):296–310.
   Web of Science ®Google Scholar
• Zeisel A, Hochgerner H, Lonnerberg P, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174(4):999–1014.
   PubMed Web of Science ®Google Scholar
• Bayraktar OA, Bartels T, Holmqvist S, et al. Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map. Nat Neurosci. 2020 Apr;23(4):500–509.
   PubMed Web of Science ®Google Scholar
• Batiuk MY, Martirosyan A, Wahis J, et al. Identification of region-specific astrocyte subtypes at single cell resolution. Nat Commun. 2020 Mar 5;11(1):1220.
   PubMed Web of Science ®Google Scholar
• Makarava N, Chang JC-Y, Baskakov IV. Region-specific sialylation pattern of prion strains provides novel insight into prion neurotropism. Int J Mol Sci. 2020;21(3):828.
   Web of Science ®Google Scholar
• Karapetyan YE, Saa P, Mahal SP, et al. Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One. 2009;4(5):e5730.
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481–487.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Race B, Williams K, et al. Microglia are critical in host defense against prion disease. J Virol. 2018;92(15):e00549–18.
   PubMed Web of Science ®Google Scholar
• Blanco-Suárez E, Caldwell AL, Allen NJ. Role of astrocyte-synapse interactions in CNS disorders. J Physiol. 2017 Mar 15;595(6):1903–1916.
   PubMed Web of Science ®Google Scholar
• Marella M, Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J Neurosci. 2004 Jan 21;24(3):620–627.
   PubMed Web of Science ®Google Scholar
• Vainchtein ID, Chin G, Cho FS, et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science. 2018 Mar 16;359(6381):1269–1273.
   PubMed Web of Science ®Google Scholar
• Rothaug M, Becker-Pauly C, Rose-John S. The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta, Mol Cell Res. 2016 Jun 1;1863(6, Part A):1218–1227.
   Web of Science ®Google Scholar
• Ben Haim L, Ceyzériat K, Carrillo-de Sauvage MA, et al. The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer’s and Huntington’s diseases. J Neurosci. 2015 Feb 11;35(6):2817–2829.
   PubMed Web of Science ®Google Scholar
• Sun D, Qu J, Jakobs TC. Reversible reactivity by optic nerve astrocytes. Glia. 2013 Aug;61(8):1218–1235.
   PubMed Web of Science ®Google Scholar
• Hara M, Kobayakawa K, Ohkawa Y, et al. Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin–N-cadherin pathway after spinal cord injury. Nat Med. 2017 Jul 1;23(7):818–828.
   PubMed Web of Science ®Google Scholar
• Yan Z, Gibson SA, Buckley JA, et al. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol. 2018 Apr;189:4–13.
   PubMed Web of Science ®Google Scholar
• Ceyzériat K, Ben Haim L, Denizot A, et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease. Acta Neuropathol Commun. 2018 Oct 16;6(1):104.
   PubMedGoogle Scholar
• Reichenbach N, Delekate A, Plescher M, et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer’s disease model. EMBO Mol Med. 2019;11(2):Feb.
   Web of Science ®Google Scholar
• Na Y-J, Jin J-K, Kim J-I, et al. JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem. 2007;103(2):637–649.
   PubMed Web of Science ®Google Scholar
• Lasmézas CI, Deslys JP, Demaimay R, et al. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J Gen Virol. 1996 Jul;77(Pt 7):1601–1609.
   PubMedGoogle Scholar
• Diedrich JF, Bendheim PE, Kim YS, et al. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. ProcNatlAcadSciUSA. 1991;88:375–379.
   PubMed Web of Science ®Google Scholar
• Jen A, Parkyn CJ, Mootoosamy RC, et al. Neuronal low density lipoprotein receptor-related protein 1 binds and endocytoses infectious fibrils via receptor cluster 4. J Cell Sci. 2010;123(2):246–255.
   PubMed Web of Science ®Google Scholar
• Canton J, Neculai D, Grinstein S. Scavenger receptors in homeostasis and immunity. Nat Rev Immunol. 2013 Sep;13(9):621–634.
   PubMed Web of Science ®Google Scholar
• Chung WS, Clarke LE, Wang GX, et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013 Dec 19;504(7480):394–400.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Katorcha E, Makarava N, et al. Inflammatory response of microglia to prions is controlled by sialylation of PrPSc. Sci Rep. 2018;8(1):e11326.
   PubMedGoogle Scholar
• Katorcha E, Makarava N, Savtchenko R, et al. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity. PLOS Pathog. 2014;10(9):e1004366.
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Katorcha E. Multifaceted role of sialylation in prion diseases. Front Neurosci. 2016;10(1):e358.
   PubMedGoogle Scholar
• Katorcha E, Makarava N, Savtchenko R, et al. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio. Sci Rep. 2015;5(1):16912.
   PubMedGoogle Scholar
• Srivastava S, Makarava N, Katorcha E, et al. Post-conversion sialylation of prions in lymphoid tissues. Proc Acad Natl Sci USA. 2015;112(48):E6654–6662.
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Katorcha E. Prion Strain-specific structure and pathology: a view from the perspective of glycobiology. Viruses. 2018;10(12):723.
   Web of Science ®Google Scholar